1. Home
  2. QLGN vs AIHS Comparison

QLGN vs AIHS Comparison

Compare QLGN & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • AIHS
  • Stock Information
  • Founded
  • QLGN 1996
  • AIHS 2014
  • Country
  • QLGN United States
  • AIHS China
  • Employees
  • QLGN N/A
  • AIHS N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • AIHS Finance: Consumer Services
  • Sector
  • QLGN Health Care
  • AIHS Finance
  • Exchange
  • QLGN Nasdaq
  • AIHS Nasdaq
  • Market Cap
  • QLGN 3.1M
  • AIHS 3.0M
  • IPO Year
  • QLGN N/A
  • AIHS 2018
  • Fundamental
  • Price
  • QLGN $1.90
  • AIHS $2.15
  • Analyst Decision
  • QLGN
  • AIHS
  • Analyst Count
  • QLGN 0
  • AIHS 0
  • Target Price
  • QLGN N/A
  • AIHS N/A
  • AVG Volume (30 Days)
  • QLGN 125.5K
  • AIHS 45.5K
  • Earning Date
  • QLGN 08-26-2025
  • AIHS 08-26-2025
  • Dividend Yield
  • QLGN N/A
  • AIHS N/A
  • EPS Growth
  • QLGN N/A
  • AIHS N/A
  • EPS
  • QLGN N/A
  • AIHS N/A
  • Revenue
  • QLGN N/A
  • AIHS $3,389,072.00
  • Revenue This Year
  • QLGN N/A
  • AIHS N/A
  • Revenue Next Year
  • QLGN N/A
  • AIHS N/A
  • P/E Ratio
  • QLGN N/A
  • AIHS N/A
  • Revenue Growth
  • QLGN N/A
  • AIHS N/A
  • 52 Week Low
  • QLGN $1.61
  • AIHS $2.10
  • 52 Week High
  • QLGN $11.50
  • AIHS $17.00
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 32.76
  • AIHS 30.18
  • Support Level
  • QLGN $1.61
  • AIHS $2.10
  • Resistance Level
  • QLGN $1.91
  • AIHS $2.35
  • Average True Range (ATR)
  • QLGN 0.16
  • AIHS 0.24
  • MACD
  • QLGN -0.01
  • AIHS 0.07
  • Stochastic Oscillator
  • QLGN 26.48
  • AIHS 5.14

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.

Share on Social Networks: